Clinical trial researches immunotherapy for cancers of the reproductive system

Female doctor and female patient

Image credit: Canva

Researchers are constantly looking for novel therapies for cancers of the reproductive system. A trial led by Andrew Blakely, M.D., Assistant Research Physician in the Surgical Oncology Program, is researching intraperitoneal immunotherapy for adults with cancers of the ovary, fallopian tube or primary peritoneum. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.

For more information, please contact Stephanie Canady, R.N., at (240) 858-7573 or identifier:  NCT05538624

NCI Protocol ID:  IRB001583

Official Title:  A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.  

For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.

Posted on Mon, 10/30/2023